Go Pro
NASDAQ:NTRB

Nutriband Q3 2025 Earnings Report

Nutriband logo
$8.13 +0.48 (+6.27%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$8.28 +0.15 (+1.89%)
As of 09/18/2026 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nutriband EPS Results

Actual EPS
-$0.12
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Nutriband Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Nutriband Announcement Details

Quarter
Q3 2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Nutriband's next earnings date is estimated for Wednesday, September 30, 2026, based on past reporting schedules.

Conference Call Resources

Nutriband Earnings Headlines

Elon Musk’s Hushed FCC Filing. Sept 25th.
Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the largest markets in the world. James Altucher, who previously flagged Nvidia in 2008 and Bitcoin in 2013, says the filing could rival Tesla, SpaceX and xAI combined. Few investors know this filing exists, but that is expected to change quickly.tc pixel
See More Nutriband Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nutriband? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nutriband and other key companies, straight to your email.

About Nutriband

Nutriband (NASDAQ:NTRB) is a medical technology company that develops, manufactures and commercializes transdermal and topical delivery products. Its technologies are designed to deliver medications or other active ingredients through the skin using adhesive patches and related wearable formats.

The company offers product development and manufacturing services for prescription, over-the-counter, consumer health and cosmetic applications. Its portfolio includes transdermal patches and other topical delivery systems, with products intended for areas such as pain management, wellness and pharmaceutical drug delivery.

Nutriband also develops its AVERSA technology, a platform designed to help deter the abuse and misuse of transdermal medications by incorporating deterrent components into patches. The company serves pharmaceutical, healthcare and consumer-product partners and is based in Orlando, Florida.

View Nutriband Profile